CVR: 81814813
DKK 38,801,270
Gross profit
Net result: DKK 10,205,639
VAN ARKENS HOLDING ApS, UL JENSEN HOLDING ApS
CVR · view ownership and management
Owner registered: VAN ARKENS HOLDING ApS
CVR · 29/06/2016
View the full event history
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees (2018). In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity in the 2026 report amounted to DKK 10,525,639.
Source: annual report 2026, Danish Business Authority
BILLEV PHARMA ApS demonstrates a strong financial trajectory, with gross profit increasing from 24.76 million DKK in 2024 to 38.80 million DKK in 2026, alongside a notable rise in profit from 3.38 million DKK to 10.21 million DKK over the same period. The company's equity has also grown significantly, reaching 10.53 million DKK in 2026, indicating a solid financial foundation. However, the absence of revenue data raises concerns about transparency and overall market position. With consistent profitability and improving margins, BILLEV PHARMA appears well-positioned within its industry, although further clarity on revenue generation would enhance its financial profile.
AI-generated summary · Generated 13/08/2026
Selskabets formål er at drive famaceutisk-medicinsk- og lignende konsulent- og agenturvirksomhed, samt dermed i forbindelse såtende virksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202601/05/2025 – 30/04/2026 | 38.8 mio. | 10.2 mio. | 15.8 mio. | 10.5 mio. | 24 | |
| 202501/05/2024 – 30/04/2025 | 31.2 mio. | 6.1 mio. | 12.3 mio. | 6.5 mio. | 21 | |
| 202401/05/2023 – 30/04/2024 | 24.8 mio. | 3.4 mio. | 6.9 mio. | 3.7 mio. | 19 | |
| 202301/05/2022 – 30/04/2023 | 29.1 mio. | 4.9 mio. | 8.9 mio. | 5.3 mio. | 21 | |
| 202201/05/2021 – 30/04/2022 | 30.2 mio. | 6 mio. | 10.4 mio. | 6.3 mio. | 21 | |
| 202101/05/2020 – 30/04/2021 | 25.6 mio. | 5.5 mio. | 9.4 mio. | 5.9 mio. | 19 | |
| 202001/05/2019 – 30/04/2020 | 21.4 mio. | 3.8 mio. | 8.1 mio. | 4.1 mio. | 16 | |
| 201901/05/2018 – 30/04/2019 | 17.5 mio. | 2.5 mio. | 5.4 mio. | 2.8 mio. | 14 | |
| 201801/05/2017 – 30/04/2018 | 17.1 mio. | 3.7 mio. | 6.8 mio. | 4 mio. | 13 | |
| 201701/05/2016 – 30/04/2017 | 14.6 mio. | 2.1 mio. | 4.8 mio. | 2.4 mio. | 13 | |
| 201601/05/2015 – 30/04/2016 | - | 2 mio. | 4.6 mio. | 2.3 mio. | - | |
| 201501/05/2014 – 30/04/2015 | 9.7 mio. | 636 t. | 3.1 mio. | 956 t. | - | |
| 201401/05/2013 – 30/04/2014 | 9.7 mio. | 517 t. | 5.3 mio. | 1.5 mio. | - | |
| 201301/05/2012 – 30/04/2013 | 9.4 mio. | 728 t. | 4.3 mio. | 2.4 mio. | - |
Compared to 1.149 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationBILLEV PHARMA ApS was founded on 22 July 1977.
BILLEV PHARMA ApS is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (industry code 749990).
BILLEV PHARMA ApS had 15 employees in 2018 according to the Danish CVR register.
BILLEV PHARMA ApS is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS.
In 2026, BILLEV PHARMA ApS reported a gross profit of DKK 38,801,270.
The management of BILLEV PHARMA ApS consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens.
Claim this page to add your logo and social links. Free to get started.
BILLEV PHARMA ApS has published its annual report for 2026. Gross profit came to DKK 38,801,270, and the net result was DKK 10,205,639.
BILLEV PHARMA ApS has published its annual report for 2025. Gross profit came to DKK 31,189,057, and the net result was DKK 6,143,854.
BILLEV PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 24,763,226, and the net result was DKK 3,378,539.
BILLEV PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 29,072,533, and the net result was DKK 4,943,056.
BILLEV PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 30,170,800, and the net result was DKK 6,013,157.
BILLEV PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 25,637,714, and the net result was DKK 5,548,863.
BILLEV PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 21,427,861, and the net result was DKK 3,786,711.
BILLEV PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 17,491,610, and the net result was DKK 2,493,022.
BILLEV PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 17,087,844, and the net result was DKK 3,726,340.
BILLEV PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 14,556,638, and the net result was DKK 2,120,209.
As of June 29, 2016, VAN ARKENS HOLDING ApS is registered as an owner of BILLEV PHARMA ApS with an ownership share of 50%.
As of June 29, 2016, UL JENSEN HOLDING ApS is registered as an owner of BILLEV PHARMA ApS with an ownership share of 50%.
BILLEV PHARMA ApS has published its annual report for 2016. The net result was DKK 2,007,612.
BILLEV PHARMA ApS has published its annual report for 2015. Gross profit came to DKK 9,747,345, and the net result was DKK 636,436.
As of April 30, 2015, Ulrikke Lynge Jensen is registered as director of BILLEV PHARMA ApS.
As of April 30, 2015, Anja Wencke van Arkens is registered as director of BILLEV PHARMA ApS.
As of April 30, 2015, Peter de Mayo Billev has stepped down as director of BILLEV PHARMA ApS.
BILLEV PHARMA ApS has published its annual report for 2014. Gross profit came to DKK 9,724,193, and the net result was DKK 516,674.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of BILLEV PHARMA ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of BILLEV PHARMA ApS.
BILLEV PHARMA ApS has published its annual report for 2013. Gross profit came to DKK 9,417,221, and the net result was DKK 727,552.
As of September 23, 2010, JUT NR. 2180 A/S has been appointed auditor of BILLEV PHARMA ApS.
As of September 23, 2010, EY Danmark A/S has stepped down as auditor of BILLEV PHARMA ApS.
As of July 22, 1977, EY Danmark A/S has been appointed auditor of BILLEV PHARMA ApS.
As of July 22, 1977, Peter de Mayo Billev is registered as director of BILLEV PHARMA ApS.
BILLEV PHARMA ApS was founded on July 22, 1977.
Companies in the same industry and area
CVR 41744162
CVR 24969355
CVR 31133475
CVR 45960285
CVR 37451835
